GTBIF
Price
$5.71
Change
+$0.17 (+3.07%)
Updated
May 15 closing price
Capitalization
1.68B
ORGO
Price
$3.03
Change
+$0.02 (+0.66%)
Updated
May 15 closing price
Capitalization
374.78M
82 days until earnings call
Ad is loading...

GTBIF vs ORGO

Header iconGTBIF vs ORGO Comparison
Open Charts GTBIF vs ORGOBanner chart's image
Green Thumb Industries
Price$5.71
Change+$0.17 (+3.07%)
Volume$265.75K
Capitalization1.68B
Organogenesis Holdings
Price$3.03
Change+$0.02 (+0.66%)
Volume$1.05M
Capitalization374.78M
GTBIF vs ORGO Comparison Chart
Loading...
GTBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GTBIF vs. ORGO commentary
May 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTBIF is a Hold and ORGO is a Hold.

Ad is loading...
COMPARISON
Comparison
May 16, 2025
Stock price -- (GTBIF: $5.71 vs. ORGO: $3.03)
Brand notoriety: GTBIF and ORGO are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: GTBIF: 62% vs. ORGO: 62%
Market capitalization -- GTBIF: $1.68B vs. ORGO: $374.78M
GTBIF [@Pharmaceuticals: Other] is valued at $1.68B. ORGO’s [@Pharmaceuticals: Other] market capitalization is $374.78M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GTBIF’s FA Score shows that 0 FA rating(s) are green whileORGO’s FA Score has 1 green FA rating(s).

  • GTBIF’s FA Score: 0 green, 5 red.
  • ORGO’s FA Score: 1 green, 4 red.
According to our system of comparison, ORGO is a better buy in the long-term than GTBIF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GTBIF’s TA Score shows that 5 TA indicator(s) are bullish while ORGO’s TA Score has 5 bullish TA indicator(s).

  • GTBIF’s TA Score: 5 bullish, 5 bearish.
  • ORGO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both GTBIF and ORGO are a good buy in the short-term.

Price Growth

GTBIF (@Pharmaceuticals: Other) experienced а -2.06% price change this week, while ORGO (@Pharmaceuticals: Other) price change was -43.26% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.68%. For the same industry, the average monthly price growth was +10.59%, and the average quarterly price growth was +26.70%.

Reported Earning Dates

ORGO is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.68% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GTBIF($1.68B) has a higher market cap than ORGO($375M). GTBIF has higher P/E ratio than ORGO: GTBIF (172.41) vs ORGO (70.25). ORGO YTD gains are higher at: -5.313 vs. GTBIF (-30.110). GTBIF has higher annual earnings (EBITDA): 253M vs. ORGO (36M). GTBIF has more cash in the bank: 185M vs. ORGO (104M). ORGO has less debt than GTBIF: ORGO (119M) vs GTBIF (541M). GTBIF has higher revenues than ORGO: GTBIF (1.02B) vs ORGO (433M).
GTBIFORGOGTBIF / ORGO
Capitalization1.68B375M449%
EBITDA253M36M703%
Gain YTD-30.110-5.313567%
P/E Ratio172.4170.25245%
Revenue1.02B433M236%
Total Cash185M104M178%
Total Debt541M119M455%
FUNDAMENTALS RATINGS
GTBIF vs ORGO: Fundamental Ratings
GTBIF
ORGO
OUTLOOK RATING
1..100
7716
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
72
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8491
PRICE GROWTH RATING
1..100
6464
P/E GROWTH RATING
1..100
9510
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GTBIF's Valuation (64) in the null industry is in the same range as ORGO (72) in the Financial Conglomerates industry. This means that GTBIF’s stock grew similarly to ORGO’s over the last 12 months.

GTBIF's Profit vs Risk Rating (100) in the null industry is in the same range as ORGO (100) in the Financial Conglomerates industry. This means that GTBIF’s stock grew similarly to ORGO’s over the last 12 months.

GTBIF's SMR Rating (84) in the null industry is in the same range as ORGO (91) in the Financial Conglomerates industry. This means that GTBIF’s stock grew similarly to ORGO’s over the last 12 months.

GTBIF's Price Growth Rating (64) in the null industry is in the same range as ORGO (64) in the Financial Conglomerates industry. This means that GTBIF’s stock grew similarly to ORGO’s over the last 12 months.

ORGO's P/E Growth Rating (10) in the Financial Conglomerates industry is significantly better than the same rating for GTBIF (95) in the null industry. This means that ORGO’s stock grew significantly faster than GTBIF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GTBIFORGO
RSI
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 12 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 3 days ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 3 days ago
83%
View a ticker or compare two or three
Ad is loading...
GTBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY590.462.87
+0.49%
SPDR® S&P 500® ETF
BTC.X103744.640000205.226560
+0.20%
Bitcoin cryptocurrency
GME28.63-0.10
-0.35%
GameStop Corp
AAPL211.45-0.88
-0.41%
Apple
TSLA342.82-4.86
-1.40%
Tesla

GTBIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GTBIF has been closely correlated with CURLF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if GTBIF jumps, then CURLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GTBIF
1D Price
Change %
GTBIF100%
+3.07%
CURLF - GTBIF
82%
Closely correlated
+0.12%
TCNNF - GTBIF
82%
Closely correlated
+3.91%
VRNOF - GTBIF
79%
Closely correlated
+3.80%
TSNDF - GTBIF
77%
Closely correlated
+8.48%
CRLBF - GTBIF
71%
Closely correlated
+3.73%
More

ORGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORGO has been loosely correlated with ANIP. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ORGO jumps, then ANIP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
+0.66%
ANIP - ORGO
49%
Loosely correlated
-1.39%
PRGO - ORGO
45%
Loosely correlated
+1.08%
AMRX - ORGO
31%
Poorly correlated
+2.04%
GTBIF - ORGO
29%
Poorly correlated
+3.07%
CURLF - ORGO
29%
Poorly correlated
+0.12%
More